Search

Your search keyword '"Mark J. Koury"' showing total 150 results

Search Constraints

Start Over You searched for: Author "Mark J. Koury" Remove constraint Author: "Mark J. Koury"
Sorry, I don't understand your search. ×
150 results on '"Mark J. Koury"'

Search Results

2. EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis

Catalog

Books, media, physical & digital resources

3. A Hybrid Computation Model to Describe the Progression of Multiple Myeloma and Its Intra-Clonal Heterogeneity

6. Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis

7. Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

8. Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease

9. MO541HEMATOLOGIC EFFICACY OF VADADUSTAT FOR ANEMIA IN PATIENTS WITH NON--DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE

10. MO539HEMATOLOGIC EFFICACY OF VADADUSTAT FOR ANEMIA IN PATIENTS WITH KIDNEY FAILURE ON DIALYSIS

11. Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis

12. The Erythropoietin Receptor Stimulates Rapid Cycling and Formation of Larger Red Cells During Mouse and Human Erythropoiesis

13. Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics

14. Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials

15. TG-Interacting Factor 1 expression quantitatively impacts survival in acute myeloid leukemia

16. Epor Stimulates Rapid Cycling and Larger Red Cells during Mouse and Human Erythropoiesis

17. Epo reprograms the epigenome of erythroid cells

18. The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysis

19. Transition to 37°C reveals importance of NADPH in mitigating oxidative stress in stored RBCs

20. A multiscale model to design therapeutic strategies that overcome drug resistance to tyrosine kinase inhibitors in multiple myeloma

21. Multi-scale Modelling of Erythropoiesis and Hemoglobin Production

22. Stress reticulocytes lose transferrin receptors by an extrinsic process involving spleen and macrophages

23. Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis

24. 3085 – THE EPOR STIMULATES RAPID CYCLING AND FORMATION OF LARGER RED CELLS DURING MOUSE AND HUMAN ERYTHROPOIESIS

25. Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD

26. A Hybrid Computation Model to Describe the Progression of Multiple Myeloma and Its Intra-Clonal Heterogeneity

27. The role of spatial organization of cells in erythropoiesis

28. Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-term Randomized Trial

29. Red blood cell production and kinetics

31. How to approach chronic anemia

32. The Safety and Tolerability of Ferric Citrate as a Phosphate Binder in Dialysis Patients

33. Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis

34. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors

35. S-Adenosylhomocysteine—a better indicator of vascular disease than homocysteine?

36. Maturational loss of the vitamin C transporter in erythrocytes

37. Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis

38. Tracking erythroid progenitor cells in times of need and times of plenty

39. Anaemia in kidney disease: harnessing hypoxia responses for therapy

40. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial

48. Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children

49. Nuclear substructure reorganization during late-stage erythropoiesis is selective and does not involve caspase cleavage of major nuclear substructural proteins

50. In vitro maturation of nascent reticulocytes to erythrocytes